Cytomegalovirus disease in AIDS: the Edinburgh experience

Area of Science:

• Infectious Diseases
• Virology
• Immunology

Background:

• Cytomegalovirus (CMV) is a common opportunistic infection in individuals with Human Immunodeficiency Virus (HIV).
• CMV disease, particularly retinitis, is a significant complication in patients with Acquired Immunodeficiency Syndrome (AIDS).

Purpose of the Study:

• To analyze the clinical characteristics and outcomes of cytomegalovirus (CMV) disease in HIV-positive patients.
• To assess the prevalence and risk factors associated with CMV disease in the context of AIDS progression.

Main Methods:

• Retrospective analysis of medical records from 557 HIV-positive patients, including 113 with AIDS.
• Identification of 17 patients diagnosed with antemortem CMV disease.
• Review of clinical data, including demographics, diagnostic findings, CD4+ lymphocyte counts, and treatment outcomes.

Main Results:

• CMV disease occurred in 17 patients (113 with AIDS), predominantly in homosexual men and injection drug users.
• All patients presented with retinitis; 6 had additional extraocular disease.
• CMV disease was an AIDS-defining diagnosis in 2 patients, with increasing prevalence over time and a 3-year CMV-free survival of 57%.
• Mean CD4+ counts were significantly lower at CMV diagnosis (17 cells/mm3) compared to AIDS diagnosis (68 cells/mm3).
• Therapy was often complicated by marrow suppression, with relapse in 11 patients.
• Mean survival after CMV diagnosis was 10.5 months, with only 3 deaths from severe visual impairment.

Conclusions:

• CMV disease is typically a late manifestation of AIDS, with increased risk correlating with longer survival.
• Frequent fundoscopy is essential for early detection of CMV retinitis in HIV-positive individuals, especially those with CD4+ counts below 100 cells/mm3.
• Despite treatment challenges and relapses, visual outcomes can be favorable with timely diagnosis and management.